Our Leaders
Meet the Team
Jeremy Stueven
MD, MBA | CHIEF EXECUTIVE OFFICER
- Board Certified in Emergency Medicine
- 15 years of real-life clinical experience
- Patient-centric, results-driven entrepreneur
- Transformative healthcare leader
Jeff Wigdahl
PhD | CHIEF TECHNOLOGY OFFICER
- PhD from the University of Padua
- Image processing, ML, and vision research
- Retinal vascular measurement software
- NIH SBIR award winner
Nate Wyatt
CHIEF INFORMATION OFFICER
- DevOps Expert
- Software engineer
- Formerly with Netskope & Microsoft
- Extensive Software Development
Alan Nolley, Jr.
JD | CHIEF ADMINISTRATIVE OFFICER
- 15 years of business law experience
- Corporate litigation
- Intellectual property experience
- Healthcare & telehealth expertise
Darwin Harrison
MAcc | CHIEF FINANCIAL OFFICER
- 30 yrs exp in healthcare finance
- 30 yrs exp in execution of HC organizations
- Extensive start-up experience
- Expert in accounting & finance
Leah Applewhite
MBA | Head of Quality & Projects
- Project mgmt and operational execution
- Quality Management Systems (QMS)
- Software as a Medical Device (SaMD)
- Regulated HC Tech compliance
Sheridan Clemens
CISSP | vCISO
- Fractional CISO
- CISSP
- Experience with SOC2, HITECH, HIPAA
- Experience with health data privacy
- Experience with security by design
Sanitas Advisors
Strategy and Go-to-Market
- Experienced team with strategy in Eye Care Industry
- Experience with pilots, commcericialization in Eye Care
- Expertise in execution of business plan
Our Advisors
John Pitcher, MD
RETINAL CONSULTANT
Vlad Matei, MD
RETINAL/MEDICAL ADVISOR
Kevin Walls
FDA EXPERT ADVISOR
Waneta Tuttle, PhD
TRAMWAY VENTURE PARTNERS
KickStart Fund
INVESTOR
Brad Vale
INVESTOR & ADVISOR
-Former Chief Innovation Officer at J&J
Lerner Venture Law
LEGAL ADVISOR
Sheppard & Mullin
HEALTHCARE/TELEHEALTH LAW
How Vitazi.ai Can Help
Technology has the potential to improve access to systemic health screening, reducing the progression of the disease for many and improving lives. If a screening could be done in minutes as part of a regular checkup, access to vital screening is solved. Going further, this could enable establishment of entirely new, systemic screening programs for several diseases within the space of Oculomics.